[1] RUDD K E,JOHNSON S C,AGESA K M,et al.Global,regional,and national sepsis incidence and mortality,1990-2017:analysis for the global burden of disease study[J].Lancet,2020,395(10219):200-211.
[2] LEMAY A C,ANZUETO A,RESTREPO M I,et al.Predictors of long-term mortality after severe sepsis in the elderly[J].Am J Med Sci,2014,347(4):282-288.
[3] BOONMEE P,RUANGSOMBOON O,LIMSUWAT C,et al.Predictors of mortality in elderly and very elderly emergency patients with sepsis:a retrospective study[J].West J Emerg Med,2020,21(6):210-218.
[4] ZHENG X,LEUNG K S,WONG M H,et al.Long non-coding RNA pairs to assist in diagnosing sepsis[J].BMC genomics,2021,22(1):275.
[5] XIE J,WANG H,KANG Y,et al.The epidemiology of sepsis in Chinese ICUs:a national cross-sectional survey[J].Crit Care Med,2020,48(3):e209-e218.
[6] CAO C,YU M,CHAI Y.Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis[J].Cell Death Dis,2019,10(10):782.
[7] SHAO S,ZHOU D,FENG J,et al.Regulation of inflammation and immunity in sepsis by e3 ligases[J].Front Endocrinol(Lausanne),2023,14:1124334.
[8] HERSHKO A,CIECHANOVER A.The ubiquitin system[J].Annu Rev Biochem,1998,67:425-479.
[9] SUMARA I,MAERKI S,PETER M.E3 ubiquitin ligases and mitosis:embracing the complexity[J].Trends Cell Biol,2008,18(2):84-94.
[10] CIECHANOVER A,ELIAS S,HELLER H,et al.“Covalent affinity” purification of ubiquitin-activating enzyme[J].J Biol Chem,1982,257(5):2537-2542.
[11] HERSHKO A,HELLER H,ELIAS S,et al.Components of ubiquitin-protein ligase system.Resolution,affinity purification,and role in protein breakdown[J].J Biol Chem,1983,258(13):8206-8214.
[12] LIAO Y,SUMARA I,PANGOU E.Non-proteolytic ubiquitylation in cellular signaling and human disease[J].Commun Biol,2022,5(1):114.
[13] BOZZA F A,SALLUH J I,JAPIASSU A M,et al.Cytokine profiles as markers of disease severity in sepsis:a multiplex analysis[J].Crit Care,2007,11(2):R49.
[14] HOTCHKISS R S,MONNERET G,PAYEN D.Sepsis-induced immunosuppression:from cellular dysfunctions to immunotherapy[J].Nat Rev Immunol,2013,13(12):862-874.
[15] HUANG M,CAI S,SU J.The pathogenesis of sepsis and potential therapeutic targets[J].Int J Mol Sci,2019,20(21):5376.
[16] EBNER P,VERSTEEG G A,IKEDA F.Ubiquitin enzymes in the regulation of immune responses[J].Crit Rev Biochem Mol Biol,2017,52(4):425-460.
[17] JANEWAY C A.Approaching the asymptote? Evolution and revolution in immunology[J].Cold Spring Harb Symp Quant Biol,1989,54(Pt 1):1-13.
[18] RAYMOND S L,HOLDEN D C,MIRA J C,et al.Microbial recognition and danger signals in sepsis and trauma[J].Biochim Biophys Acta Mol Basis Dis,2017,1863(10 Pt B):2564-2573.
[19] WU J,CHEN Z J.Innate immune sensing and signaling of cytosolic nucleic acids[J].Annu Rev Immunol,2014,32:461-488.
[20] KAWAI T,AKIRA S.The role of pattern-recognition receptors in innate immunity:update on toll-like receptors[J].Nat Immunol,2010,11(5):373-384.
[21] TEMPERLEY N D,BERLIN S,PATON I R,et al.Evolution of the chicken toll-like receptor gene family:a story of gene gain and gene loss[J].BMC Genomics,2008,9:62.
[22] METZGER M B,PRUNEDA J N,KLEVIT R E,et al.Ring-type e3 ligases:master manipulators of e2 ubiquitin-conjugating enzymes and ubiquitination[J].Biochim Biophys Acta,2014,1843(1):47-60.
[23] WALSH M C,LEE J,CHOI Y.Tumor necrosis factor receptor-associated factor 6(traf6) regulation of development,function,and homeostasis of the immune system[J].Immunol Rev,2015,266(1):72-92.
[24] JIANG X,CHEN Z J.The role of ubiquitylation in immune defence and pathogen evasion[J].Nat Rev Immunol,2011,12(1):35-48.
[25] WANG C,DENG L,HONG M,et al.Tak1 is a ubiquitin-dependent kinase of MKK and IKK[J].Nature,2001,412(6844):346-351.
[26] PETERSEN S L,WANG L,YALCIN-CHIN A,et al.Autocrine TNFalpha signaling renders human cancer cells susceptible to SMAC-mimetic-induced apoptosis[J].Cancer Cell,2007,12(5):445-456.
[27] HUANG S,CHENG A,WANG M,et al.Viruses utilize ubiquitination systems to escape TLR/RLR-mediated innate immunity[J].Front Immunol,2022,13:1065211.
[28] ZHANG J,CAO L,GAO A,et al.E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2[J].Cell Death Differ,2023,30(4):966-978.
[29] BOONE D L,TURER E E,LEE E G,et al.The ubiquitin-modifying enzyme A20 is required for termination of toll-like receptor responses[J].Nat Immunol,2004,5(10):1052-1060.
[30] LIU J,HAN C,XIE B,et al.Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator nemo[J].Nat Immunol,2014,15(7):612-622.
[31] ARIMOTO K,FUNAMI K,SAEKI Y,et al.Polyubiquitin conjugation to NEMO by triparite motif protein 23(TRIM23) is critical in antiviral defense[J].Proc Natl Acad Sci U S A,2010,107(36):15856-15861.
[32] KAWAI T,TAKAHASHI K,SATO S,et al.Ips-1,an adaptor triggering RIG-I-and MDA5-mediated type I interferon induction[J].Nat Immunol,2005,6(10):981-988.
[33] SAITO T,HIRAI R,LOO Y M,et al.Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2[J].Proc Natl Acad Sci U S A,2007,104(2):582-587.
[34] SHARMA S,TENOEVER B R,GRANDVAUX N,et al.Triggering the interferon antiviral response through an IKK-related pathway[J].Science,2003,300(5622):1148-1151.
[35] INN K S,GACK M U,TOKUNAGA F,et al.Linear ubiquitin assembly complex negatively regulates RIG-I-and trim25-mediated type I interferon induction[J].Mol Cell,2011,41(3):354-365.
[36] OSHIUMI H,MATSUMOTO M,HATAKEYAMA S,et al.Riplet/RNF135,a ring finger protein,ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection[J].J Biol Chem,2009,284(2):807-817.
[37] ZHU Q,YU T,GAN S,et al.TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination[J].J Exp Med,2020,217(7):e20192083.
[38] CHEN Y Y,RAN X H,NI R Z,et al.TRIM28 negatively regulates the RLR signaling pathway by targeting MAVS for degradation via K48-linked polyubiquitination[J].J Biol Chem,2023,299(5):104660.
[39] AKTHER M,HAQUE M E,PARK J,et al.NLRP3 ubiquitination-a new approach to target NLRP3 inflammasome activation[J].Int J Mol Sci,2021,22(16):8780.
[40] QIN Y,LI Q,LIANG W,et al.TRIM28 sumoylates and stabilizes NLRP3 to facilitate inflammasome activation[J].Nat Commun,2021,12(1):4794.
[41] XU T,YU W,FANG H,et al.Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation[J].Cell Death Differ,2022,29(8):1582-1595.
[42] HUMPHRIES F,BERGIN R,JACKSON R,et al.The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome[J].Nat Commun,2018,9(1):1560.
[43] SONG H,LIU B,HUAI W,et al.The E3 ubiquitin ligase TRIM31 attenuates nlrp3 inflammasome activation by promoting proteasomal degradation of NLRP3[J].Nat Commun,2016,7:13727.
[44] HAN S,LEAR T B,JEROME J A,et al.Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase[J].J Biol Chem,2015,290(29):18124-18133.
[45] MUÑOZ-PLANILLO R,KUFFA P,MARTÍNEZ-COLÓN G,et al.K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter[J].Immunity,2013,38(6):1142-1153.
[46] TANG J,TU S,LIN G,et al.Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia[J].J Exp Med,2020,217(4):e20182091.
[47] DEMPSEY A,BOWIE A G.Innate immune recognition of DNA:a recent history[J].Virology,2015,479-480:146-152.
[48] TSUCHIDA T,ZOU J,SAITOH T,et al.The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA[J].Immunity,2010,33(5):765-776.
[49] LIU H,MOURA-ALVES P,PEI G,et al.CGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity[J].EMBO Rep,2019,20(4):e46293.
[50] DOBBS N,BURNAEVSKIY N,CHEN D,et al.STING activation by translocation from the ER is associated with infection and autoinflammatory disease[J].Cell Host Microbe,2015,18(2):157-168.
[51] LIU S,CAI X,WU J,et al.Phosphorylation of innate immune adaptor proteins MAVS,STING,and TRIF induces IRF3 activation[J].Science,2015,347(6227):aaa2630.
[52] NI G,KONNO H,BARBER G N.Ubiquitination of STING at lysine 224 controls IRF3 activation[J].Sci Immunol,2017,2(11):eaah7119.
[53] ZHANG J,HU M M,WANG Y Y,et al.TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination[J].J Biol Chem,2012,287(34):28646-28655.
[54] GUO Y,JIANG F,KONG L,et al.OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING[J].Cell Mol Immunol,2021,18(8):1945-1955.
[55] RIMMELÉ T,PAYEN D,CANTALUPPI V,et al.Immune cell phenotype and function in sepsis[J].Shock,2016,45(3):282-291.
[56] GERMAIN R N.T-cell development and the CD4-CD8 lineage decision[J].Nat Rev Immunol,2002,2(5):309-322.
[57] SMITH-GARVIN J E,KORETZKY G A,JORDAN M S.T cell activation[J].Annu Rev Immunol,2009,27:591-619.
[58] ZINNGREBE J,MONTINARO A,PELTZER N,et al.Ubiquitin in the immune system[J].EMBO Rep,2014,15(1):28-45.
[59] NEDEVA C.Inflammation and cell death of the innate and adaptive immune system during sepsis[J].Biomolecules,2021,11(7):1011.
[60] THAM E L,SHRIKANT P,MESCHER M F.Activation-induced nonresponsiveness:a Th-dependent regulatory checkpoint in the CTL response[J].J Immunol,2002,168(3):1190-1197.
[61] MOSMANN T R,CHERWINSKI H,BOND M W,et al.Two types of murine helper T cell clone.I.Definition according to profiles of lymphokine activities and secreted proteins[J].J Immunol,1986,136(7):2348-2357.
[62] ZHANG X,GAO L,LEI L,et al.A myd88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen chlamydia muridarum[J].J Immunol,2009,183(2):1291-1300.
[63] HUANG H,JEON M S,LIAO L,et al.K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling[J].Immunity,2010,33(1):60-70.
[64] BALAGOPALAN L,ASHWELL B A,BERNOT K M,et al.Enhanced T-cell signaling in cells bearing linker for activation of T-cell(LAT) molecules resistant to ubiquitylation[J].Proc Natl Acad Sci U S A,2011,108(7):2885-2890.
[65] ARNON T I,HORTON R M,GRIGOROVA I L,et al.Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress[J].Nature,2013,493(7434):684-688.
[66] DONG X,TU H,QIN S,et al.Insights into the roles of B cells in patients with sepsis[J].J Immunol Res,2023,2023:7408967.
[67] SEN R.Control of B lymphocyte apoptosis by the transcription factor NF-kappaB[J].Immunity,2006,25(6):871-883.
[68] KUROSAKI T,HIKIDA M.Tyrosine kinases and their substrates in B lymphocytes[J].Immunol Rev,2009,228(1):132-148.
[69] SCHUMAN J,CHEN Y,PODD A,et al.A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation[J].Blood,2009,113(19):4566-4574.
[70] PIAO W,XIONG Y,FAMULSKI K,et al.Regulation of T cell afferent lymphatic migration by targeting LTβR-mediated non-classical NFκB signaling[J].Nat Commun,2018,9(1):3020.
[71] FELTHAM R,MOULIN M,VINCE J E,et al.Tumor necrosis factor(TNF) signaling,but not tweak(TNF-like weak inducer of apoptosis)-triggered cIAP1(cellular inhibitor of apoptosis protein 1) degradation,requires cIAP1 RING dimerization and E2 binding[J].J Biol Chem,2010,285(23):17525-17536.
[72] VARFOLOMEEV E,WAYSON S M,DIXIT V M,et al.The inhibitor of apoptosis protein fusion c-IAP2.Malt1 stimulates NF-κB activation independently of TRAF1 and TRAF2[J].J Biol Chem,2006,281(39):29022-29029.
[73] XIAO N,ETO D,ELLY C,et al.The E3 ubiquitin ligase itch is required for the differentiation of follicular helper T cells[J].Nat Immunol,2014,15(7):657-666.
[74] LIU X,ZHANG Y,WEI Y,et al.The E3 ubiquitin ligase itch is required for B-cell development[J].Sci Rep,2019,9(1):421.
[75] SATPATHY S,WAGNER S A,BELI P,et al.Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation[J].Mol Syst Biol,2015,11(6):810.
[76] HANPUDE P,BHATTACHARYA S,DEY A K,et al.Deubiquitinating enzymes in cellular signaling and disease regulation[J].IUBMB Life,2015,67(7):544-555.
[77] GENG J,HUANG X,LI Y,et al.Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis[J].Respir Res,2015,16:1024.
[78] WU B,MIAO X,YE J,et al.The protective effects of protease inhibitor MG-132 on sepsis-induced acute lung rats and its possible mechanisms[J].Med Sci Monit,2019,25:5690-5699.
[79] MATSUO S,SHARMA A,WANG P,et al.PYR-41,a ubiquitin-activating enzyme E1 inhibitor,attenuates lung injury in sepsis[J].Shock,2018,49(4):442-450. |
